Posted on 4/5/19
Antares Pharma: It's The Business Model, Stupid
Summary Regardless of the company’s growing, diversified portfolio and pipeline of drugs, Antares stock continues to trade like it is a one-product company. Negative trial results . . .
Posted on 4/5/19
Antares Pharma: It's The Business Model, Stupid
SummaryRegardless of the company’s growing, diversified portfolio and pipeline of drugs, Antares stock continues to trade like it is a one-product company.Negative trial results for partnered . . .

